From: CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin
Coefficients: | ||||
---|---|---|---|---|
Estimate | Std. Error | T value | Pr(>ItI) | |
(Intercept) | 1.10562 | 3.19827 | 0.346 | 0.7304 |
ARB | 5.35886 | 2.23582 | 2.397 | 0.0187* |
Age | 0.02953 | 0.05256 | 0.562 | 0.5757 |
genoAG | 0.91455 | 1.70261 | 0.537 | 0.5925 |
genoGG | 4.13718 | 1.86285 | 2.221 | 0.0290* |